These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36075566)

  • 21. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
    Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
    Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
    Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana.
    Akuffo R; Brandful JA; Zayed A; Adjei A; Watany N; Fahmy NT; Hughes R; Doman B; Voegborlo SV; Aziati D; Pratt D; Awuni JA; Adams N; Dueger E
    BMC Infect Dis; 2016 Jul; 16():324. PubMed ID: 27392037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crimean-Congo hemorrhagic fever virus-infected hepatocytes induce ER-stress and apoptosis crosstalk.
    Rodrigues R; Paranhos-Baccalà G; Vernet G; Peyrefitte CN
    PLoS One; 2012; 7(1):e29712. PubMed ID: 22238639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus.
    Xu ZS; Du WT; Wang SY; Wang MY; Yang YN; Li YH; Li ZQ; Zhao LX; Yang Y; Luo WW; Wang YY
    Cell Res; 2024 Feb; 34(2):140-150. PubMed ID: 38182887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of codon usage bias of Crimean-Congo hemorrhagic fever virus and its adaptation to hosts.
    Rahman SU; Yao X; Li X; Chen D; Tao S
    Infect Genet Evol; 2018 Mar; 58():1-16. PubMed ID: 29198972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Crimean-Congo Hemorrhagic Fever Virus and Aigai Virus in Life Cycle Modeling Systems Reveals a Difference in L Protein Activity.
    Pickin MJ; Devignot S; Weber F; Groschup MH
    J Virol; 2022 Jul; 96(13):e0059922. PubMed ID: 35695578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system.
    Suda Y; Fukushi S; Tani H; Murakami S; Saijo M; Horimoto T; Shimojima M
    Arch Virol; 2016 Jun; 161(6):1447-54. PubMed ID: 26935918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crimean-Congo Hemorrhagic Fever.
    Shayan S; Bokaean M; Shahrivar MR; Chinikar S
    Lab Med; 2015; 46(3):180-9. PubMed ID: 26199256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1.
    Hu YL; Zhang LQ; Liu XQ; Ye W; Zhao YX; Zhang L; Qiang ZX; Zhang LX; Lei YF; Jiang DB; Cheng LF; Zhang FL
    Front Cell Infect Microbiol; 2023; 13():1121163. PubMed ID: 37026060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
    Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
    Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
    Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
    Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean-Congo hemorrhagic fever virus.
    Wang Q; Cao R; Li L; Liu J; Yang J; Li W; Yan L; Wang Y; Yan Y; Li J; Deng F; Zhou Y; Wang M; Zhong W; Hu Z
    Antiviral Res; 2022 Mar; 199():105273. PubMed ID: 35257725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in understanding Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Feldmann H
    F1000Res; 2018; 7():. PubMed ID: 30416710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryo-EM structure of glycoprotein C from Crimean-Congo hemorrhagic fever virus.
    Li N; Rao G; Li Z; Yin J; Chong T; Tian K; Fu Y; Cao S
    Virol Sin; 2022 Feb; 37(1):127-137. PubMed ID: 35234630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crimean-Congo hemorrhagic fever virus infection triggers the upregulation of the Wnt signaling pathway inhibitor genes.
    Papp H; Zeghbib S; Földes F; Banfai K; Madai M; Kemenesi G; Urbán P; Kvell K; Jakab F
    Virus Genes; 2020 Aug; 56(4):508-514. PubMed ID: 32335793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.
    Zivcec M; Safronetz D; Scott D; Robertson S; Ebihara H; Feldmann H
    J Infect Dis; 2013 Jun; 207(12):1909-21. PubMed ID: 23417661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus.
    Zivcec M; Scholte FE; Spiropoulou CF; Spengler JR; Bergeron É
    Viruses; 2016 Apr; 8(4):106. PubMed ID: 27110812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38.
    Mishra AK; Moyer CL; Abelson DM; Deer DJ; El Omari K; Duman R; Lobel L; Lutwama JJ; Dye JM; Wagner A; Chandran K; Cross RW; Geisbert TW; Zeitlin L; Bornholdt ZA; McLellan JS
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31996434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.